All in One Drop

2009 AGM, March 30, 2010

Cover to be like annual report

All in One Drop

2

Safe harbour statement

This presentation may contain forward-looking statements. Various factors could

cause actual results to differ materially from those projected in forward-looking

statements, including comments predicting the timing of financings, strategic

partnering, regulatory actions, or the capabilities of the platform. Although the

Company believes that the forward-looking statements contained herein are

reasonable, it can give no assurance that the Company‟s expectations are

correct. All forward-looking statements are expressly qualified in their entirety by

this Cautionary Statement. This presentation should not be considered an

official disclosure document of the Company.

This document is for information purposes only and is not intended to be used to

solicit the sale of securities.

SQI Diagnostics™ Inc. PRIVATE and CONFIDENTIAL – NOT FOR

DISTRIBUTION without the express written consent of SQI Diagnostics Inc.

All in One Drop 3

SQI

Diagnostics

Multiplexing,

Miniaturization and

Automation.

Analyze multiple biomarkers,

Deliver accurate patient

results in less time,

Reduce labor, and

Increase profits …

All in One Drop

All in One Drop 4

SQiDworks™ – the first fully-automated

multiplexing workstation for diagnostic

microarrays.

IgXPLEX™

Patented Microarray Assay

providing 3 strategic customers benefits

Confidence, Profit and Growth

All in One Drop

SQiDworks & RA Assay

5

Canada

European Union

United States

cleared for sale in

All in One Drop

Value creation

6

Microarray concept

Multipexed array demo

Automated array

scanning

A-G-M calibration

Fully automated

system

Health Cda approval

Surface optimization

Printing optimization

RA panel validation

FDA clearance

U.S. market launch

Complete AI panels

1st ID panels filed

SQiDman launch

2005 2006 2007 2008 2009 2010 2011

Scale up capital

Technology investment

All in One Drop

7

MultiplexingWhy?

All in One Drop

8

Current multiple biomarker testing is labour intensive

1 test

1 unit of reagents

1 unit of labour

1 result

6 tests

6 units of reagents

6 units of labour

6 results

SINGLE biomarker testing

MULTIPLEbiomarker testing

No economies of scale

for multiple testing!

All in One Drop

Study of 324 clinical laboratories by Chi Solutions in 2008

9

57.9%Labor &

Benefits

20.9%Supplies

0.6% Lease/Rental

1.5% Repair

2.4% Depreciation

6.0% Other

8.9% Send Outs

All in One Drop

Evolution with Purpose: 4th Generation

Discovery Antigen / Antibody

ELISA

Multiple samples on single plate

Lab Automation

Multiple samples in single run

Bead Based Multiplexing

Multiple analytes/samples

IgXplex 2010

Multiple analytes

Isotypes

Samples

In single run

10

SQI Diagnostics‟ IgXplex:

The Next Generation

Immunoassay

All in One Drop

11

TechnologyPlatform and Assay

All in One Drop 12

Complete automation of all assay steps

Integrates with standard lab automation systems

Throughput: 222 patients / run

~700 patient results / hour .

Productivity!

Load & Go

All in One Drop 13

Productivity!

Load & Go

Fully Automated Platform Comparison: Isotyping 6 Analytes

SQI- IgXplex Auto-Luminex Auto -ELISA

Reagent Kits: 1 Reagent Kits: 6 Reagent Kits: 18

Consumable Sets: 1 Consumable Sets: 6 Consumable Sets: 18

Hands On Time: 30 Minutes Hands On Time: 5 Hours Hands On Time: 9 Hours

Steps Needed: 5 Steps Needed: 126 Steps Needed: 90

All in One Drop

14

IGXPLEX™

• Multiplexing at 2 levels – antigen

& antibody class (IgX PLEX™)

• Industry-standard 96 well format

• 74 patients per consumable

12plex‟d = 888 biomarker results

per consumable

• Up to 12 biomarkers tested

quantitatively and 24 screening

• 23 within well, 72 within plate

multiple tests / multiple patients

results with < one unit of labour

1 well

1 patient

Multiple Results

All in One Drop

15

BusinessValue Proposition

All in One Drop

16

SQI Diagnostics value proposition: dramatic economies of scale

Traditional manual biomarker testing

74 patients | 9 biomarker

requiring 18 “plates”

SQI Diagnostics biomarker testing

74 patients | 9 biomarkers

requiring 1 “plate”

~ 3 seconds

per biomarkerTechnician „hands-on‟ time

~ 4 minutes

per biomarker Technician „hands-on‟ time

Automated micro array technology powering a technology shift…

80 X

Reduction

All in One Drop

17

Profit increases by up to $40 per patient in 9-

plex panel

36 minutes / patient

Beta2 CL PS

Patient Well Costs $12.00 $12.00 $14.25

Reagent Cost 1.50 1.50 1.50

Tech Labour 12.00 12.00 12.00

Lab Overhead 1.20 1.20 1.43

Total: $82.58

Costs Beta 2 Cardio-L PS

Patient Well Cost $38.25

0.23

0.25

3.82

Reagent Cost

Tech Labour

Lab Overhead

Total: $42.55Total: $82.58

0.3 minutes / patient

18 microtiter plates required

Current Method IgX-Plex

All in One Drop

18

Sales Funnel

“Current” Target Market

Labs in USA14,000

300

60

6–10

Current Focus Accounts

Target Installs for

2010

Meetings Completed/Scheduled20

1 Completed Validation (to date)

18

All in One Drop

All in One Drop

19

Candidate Panels Insight Proof of

Concept

Assay

Develop

Automation Verification Multisite

Validation

Regulatory

Submission

Six-Month Internal Development

Timeframe

Infliximab (RUO)-3x

Vasculitis-4x RA v2Auto Hep

Renal

Food

Intolerance

Celiac-4x

Thyroid-3x

Lupus-12x

BOTX-3x

IBD-8x

Current Product Pipeline

Customer

Delivery

APS-9x

All in One Drop

Goals for 2010

Three assays submitted to FDA

FDA Clearance for at least one

New Product

Two OEM products delivered

Multiple Health Canada

Approvals

Six Customer installation Sites

Customer Revenue20

All in One Drop

21

Company overview

Headquarters: Toronto, Ontario

Founded: 1999

Symbol: TSX.V SQD

Financial data :27,193,000 shares issued and outstanding

32,279,000 shares on a fully diluted basis

$26.5 million raised since 2004

$8.543 million current assets as at December 31, 2009

Cash in place through 2011

Cash burn rate of ~$625,000 per month

All in One Drop

2009 AGM, March 30, 2010

Cover to be like annual report